Franklin Resources Inc Atossa Therapeutics, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.85 - $1.28 $19,748 - $29,738	-23,233 Reduced 32.6%	48,040 $52,000
Q1 2022 May 13, 2022	BUY	$1.11 - $1.74 $79,113 - $124,015	71,273 New	71,273 $89,000
Q4 2021 Feb 11, 2022	SELL	$1.6 - $3.27 $22,880 - $46,761	-14,300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.89 - $6.4 $41,327 - $91,520	14,300 New	14,300 $47,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.